Parkinson's disease, or simply Parkinson's, is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. As the disease worsens, non-motor symptoms become more common. The symptoms usually emerge slowly. Early in the disease, the most obvious symptoms are shaking, rigidity, slowness of movement, and difficulty with walking. Thinking and behavioral problems may also occur. Dementia becomes common in the advanced stages of the disease. Depression and anxiety are also common, occurring in more than a third of people with PD. Other symptoms include sensory, sleep, and emotional problems. The main motor symptoms are collectively called "parkinsonism", or a "parkinsonian syndrome".
Components of the Book:
- Chapter 1
Small (autonomic) and large fiber neuropathy in Parkinson disease and parkinsonism
- Chapter 2
The role of skin biopsy in differentiating idiopathic Parkinson’s disease from other types of parkinsonism
- Chapter 3
Chemotherapy-induced peripheral neuropathy: part 1—current state of knowledge and perspectives for pharmacotherapy
- Chapter 4
The effect of n-3 polyunsaturated fatty acids on incidence and severity of oxaliplatin induced peripheral neuropathy: a randomized controlled trial
- Chapter 5
Chemotherapy-induced peripheral neuropathy—part 2: focus on the prevention of oxaliplatin-induced neurotoxicity
- Chapter 6
Motor and non-motor outcomes in patients with advanced Parkinson’s disease treated with levodopa/carbidopa intestinal gel: final results of the GREENFIELD observational study
- Chapter 7
Looking beyond the brain to improve the pathogenic understanding of Parkinson’s disease: implications of whole transcriptome profiling of Patients’ skin
- Chapter 8
Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluid
- Chapter 9
Effects of a sensory-motor orthotic on postural instability rehabilitation in Parkinson’s disease: a pilot study
- Chapter 10
Perimetric and retinal nerve fiber layer findings in patients with Parkinson’s disease
- Chapter 11
Movement smoothness during a functional mobility task in subjects with Parkinson’s disease and freezing of gait – an analysis using inertial measurement units
- Chapter 12
Audio-Biofeedback training for posture and balance in Patients with Parkinson's disease
- Chapter 13
Distant delivery of a mindfulness-based intervention for people with Parkinson’s disease: the study protocol of a randomised pilot trial
- Chapter 14
Evaluation of oxidative stress markers in pathogenesis of diabetic neuropathy
- Chapter 15
A customized high-resolution array-comparative genomic hybridization to explore copy number variations in Parkinson’s disease
Readership:
Students, academics, teachers and other people attending or interested in Peripheral Neuropathy in Parkinson’s Disease
L. McCracken
L. McCracken, Health Psychology, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
J. V. Hindle
J. V. Hindle, School of Psychology, Bangor University, Bangor, UK
A. Bogosian
A. Bogosian, Division of Health Services Research & Management, School of Health Sciences, City, University of London, London, UK
Neil P. Robertson
Neil P. Robertson, Department of Neurology, Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, Cardiff, UK
Giuseppe Meco
Giuseppe Meco, Department of Neurology and Psychiatry (Parkinson’s Centre), Research Centre of Social Diseases (CIMS), Sapienza University, Rome, Italy
Ewald Max Hennig
Ewald Max Hennig, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia
and more...